UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 10-K

     [X]  ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF 
          THE SECURITIES EXCHANGE ACT OF 1934

              For the Fiscal Year Ended: February 28, 1992

     [ ]  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
          OF THE SECURITIES EXCHANGE ACT OF 1934

              For the Transition Period From ____ to ____
              
                  ---------------------------------------------
                         Commission File Number: 0-9798

                             Medical Monitors, Inc.
              ----------------------------------------------------
             (Exact name of Registrant as specified in its charter)

                DELAWARE                                   95-2930683
      -----------------------------                    ----------------------
     (State or other jurisdiction of                   (I.R.S. Employer
     Incorporation or organization)                    Identification No.)

     1990 Westwood Blvd., Penthouse, Los Angeles, CA                   90025
     ------------------------------------------------------          --------- 
     (Address of principal executive offices)                        (Zip Code)
                      
     Registrant's telephone number, including area code:      (310) 441-0090

     Securities registered pursuant to Section 12(b) of the Act:    None

     Securities  registered  pursuant to Section 12(g) of the Act: Common Stock
                                                                 $.01 Par Value

     Indicate  by check mark  whether the  Registrant  (1) has filed all reports
required to be filed by Section 13 or 15 (d) of the  Securities  Exchange Act of
1934 during the preceding 12 months (or shorter  period that the  Registrant was
required  to file  such  reports),  and  (2) has  been  subject  to such  filing
requirements for the past 90 days. Yes [ ]  No   [X]

     Indicate by check mark if disclosure of delinquent  filers pursuant to Item
405 of Regulation S-K is not contained herein, and will not be contained, to the
best of registrant's  knowledge,  in definitive proxy or information  statements
incorporated by reference in Part II of this Form 10-K or any amendments to this
Form 10-K. [X]

     As of February 28, 1992 there were  50,000,000  shares of the  Registrant's
Common Stock, $.01 par value, outstanding.  The aggregate market value of shares
of Common Stock held by  non-affiliates  of the Registrant  cannot be determined
since there has been no active  trading  market for such Common Stock during the
period covered by this report.

<PAGE>

                              MEDICAL MONITORS INC.

                                    FORM 10-K

                
                                      INDEX

                                                                          Page
                                     PART I

Item 1.   Business ......................................................  3

Item 2.   Properties ....................................................  4

Item 3.   Legal Proceedings .............................................  4

Item 4.   Submission of Matters to a Vote of Security Holders ...........  4


                                     PART II

Item 5.   Market for the Registrant's Common Equity and 
          Related Stockholder Matters ...................................  4

Item 6.   Selected Financial Data .......................................  4

Item 7.   Management Discussion and Analysis of Financial 
          Condition and Results of Operations ...........................  4

Item 8.   Financial Statements and Supplementary Data ...................  5

Item 9.   Changes in and Disagreements with Accountants on Accounting 
          and Financial Disclosure ......................................  5

                                    PART III

Item 10.  Directors and Executive Officers of the Registrant ............  11

Item 11.  Executive Compensation ........................................  12

Item 12.  Security Ownership of Certain Beneficial 
          Owners and Management .........................................  12

Item 13.  Certain Relationships and Related Transactions ................  13

                                     PART IV

Item 14.  Exhibits, Financial Statements Schedules and 
          Reports on Form 8-K ...........................................  14

          Signatures ....................................................  15

                                     Page 2

<PAGE>

                                     PART I

Item 1.   The Business

General

     Medical Monitors, Inc. (the "Registrant"), is a corporation organized under
Delaware law in February, 1975. The Registrant previously developed an automated
electronic  blood pressure  measuring  device that can be used by individuals to
measure their own blood pressure without training or assistance.  The Registrant
has experienced  significant  operating losses since inception,  and at February
28, 1992 had an  accumulated  deficit of  $1,960,211.  The  Registrant  has been
without any material  funds to develop and expand its business since the Fall of
1981 when management determined that the Registrant should remain in an inactive
status  pending the  development of an improved AES Unit. No such improve of the
AES Unit was undertaken by the  Registrant  and the has been no active  business
operations. Since that time, Harry Shuster, the sole officer and director of the
Registrant has personally  financed the  maintenance of the Registrant by making
non-interest bearing loans to the Registrant. There can be no assurance that Mr.
Shuster will be willing or able to continue  personally finance the Registrant's
operations or maintenance of the Registrant in the future.

     At present, the Registrant has no active business.  The Registrant proposes
to combine with an existing,  privately-held Registrant which is profitable and,
in  management's  view, has growth  potential  (irrespective  of the industry in
which  it  is  engaged).   A   combination   may  be  structured  as  a  merger,
consolidation,  exchange of the Registrant's Common Stock for stock or assets or
any  other  form  which  will  result  in  the  combined  enterprise's  being  a
publicly-held  corporation.  The  Registrant  will pursue a  combination  with a
Registrant or business  enterprise  that satisfies its  combination  suitability
standards by  advertising  in one or more  newspapers  or magazines to establish
contact  with, or by otherwise  contacting,  selected  privately-held  companies
which are  profitable  and are believed to have growth  potential.  There are no
assurances  that  management of the Registrant will be able to locate a suitable
combination  partner or that a combination can be structured on terms acceptable
to the Registrant.

     Pending  negotiation  and  consummation  of a  combination,  the Registrant
anticipates  that  it  will  have  limited  business  activities,  will  have no
significant  sources  of  revenue  and will  incur no  significant  expenses  or
liabilities. If expenses are incurred and funds are necessary the Registrant may
undertake  a private  placement  of its  common  stock or borrow  the  necessary
capital from its officers and directors.  Should  necessary  funds be available,
the Registrant will engage  attorneys,  accountants  and/or other consultants to
evaluate and assist in completing a potential combination.

Capital Expenditures

     The Registrant plans no significant expenditures.

Employees

     The Company  currently has one  employee,  Harry  Shuster,  who is the sole
officer  and  director  of  the  Company.  The  Company  is not a  party  to any
collective bargaining agreement.

                                     Page 3

<PAGE>

Item 2.   Properties

     The Company owns no real property or other  materially  important  physical
facilities. The Company uses offices maintained personally by Harry Shuster, the
sole officer and director of the Company, at no cost to the Company.

Item 3.   Legal Proceedings

     There are no material  pending legal  proceedings to which the Company is a
party or of which any of its property is subject.

Item 4.   Submission of Matters to a Vote of Security Holders.

     No matter was submitted to a vote of security holders of the Company during
the fourth  quarter of the fiscal  year ended  February  28,  1992,  through the
solicitation of proxies, or otherwise.

                                     PART II

Item 5.   Market for Registrant's Common Equity and Related Stockholder Matters.

     The Common Stock,  $.01 par value,  or the Company is very thinly traded in
over-the-counter market with the bid and ask ranging between $.01 and $.02.

     There were approximately  1,746 holders of record of the Common Stock, $.0l
par value, of the Company as of February 28, 1992.

     The  Company  has paid no cash  dividends  on its Common  Stock,  $.001 par
value, in the past and does not  contemplate  paying dividend in the foreseeable
future. Future declaration of dividends, if any, will be determined by the Board
of Directors in its  discretion and will depend upon  conditions  then existing,
including  the   availability  of  funds,   requirements   for  working  capital
expenditures and debt retirement,  general business condition and prospects, and
other factors.  The General  Corporation  Law of the State of Delaware  provides
that dividends may be declared and paid only out of surplus,  as defined in such
statute, or it there is no such surplus,  only out of net profits for the fiscal
year in which the dividend is paid and/or the preceding fiscal year. The Company
has no surplus,  as defined in the  statute,  and has not had any net profits in
either of its last two fiscal years. Accordingly,  any future dividends can only
be declared and paid out of current earnings, if any.

Item 6.   Selected Financial Data

     See the Financial Statements of the Registrant in Item 8.

Item 7.   Management's Discussion And Analysis Of Financial Condition 
          and Results Of Operations.

General

     The Company has experienced severe working capital shortages during most of
the period since 1976,  primarily  because of its  prolonged  experience  in its
research and development  stage and its subsequent  inability to obtain delivery
of product  from its  manufactured.  The  Registrant  had been  primarily  a one
product  company,  engaged in the development of its automated  electronic blood
pressure  measuring  device known as the AES Unit.  Since February 28, 1985, the
Company has had no active business  operations of any kind. All risk inherent in
new and inexperienced enterprises are inherent the Company's business.

                                     Page 4

<PAGE>

The  Company  has not  made a  formal  study of the  economic  potential  of any
business.  At the present, the Company has not identified any assets or business
opportunities for acquisition.

     As of  February  28, 1992 the Company  has no  liquidity  and no  presently
available capital resources, such as credit lines, guarantees, etc. and should a
merger or acquisition prove unsuccessful, it is possible that the Company may be
dissolved by the State of Delaware for failing to file  reports,  at which point
the Company would no longer be a viable corporation under Delaware law and would
be unable to function as a legal entity. Should management decide not to further
pursue its acquisition  activities,  management may abandon its activities asked
the  shares of the  Company  would  become  worthless.  However,  the  Company's
officers,  directors and majority shareholder,  have made an oral undertaking to
make  loans to the  Company in amounts  sufficient  to enable it to satisfy  its
reporting  requirements  and  other  obligations  incumbent  on it  as a  public
company,  and to  commence,  on a limited  basis,  the process of  investigating
possible  merger  and  acquisition   candidates.   The  Company's  status  as  a
publicly-held  corporation may enhance its ability to locate potential  business
ventures.  The loans will be  interest  free and are  intended to be repaid at a
future date, or when the Company shall have  received  sufficient  funds through
any business  acquisition.  The loans are intended to provide for the payment of
filing  fees,.   professional   fees,   printing  and  copying  fees  and  other
miscellaneous fees.

     Based on current economic and regulatory  conditions,  Management  believes
that it is possible.  if not probable,  for a company like the Company,  without
assets  or  liabilities,  to  negotiate  a merger or  acquisition  with a viable
private company.  The opportunity arises  principally  because of the high legal
and  accounting  fees and the length of time  associated  with the  registration
process of "going public". However, should any of these conditions change, it is
very possible that there would be little or no economic  value for anyone taking
over control of the Company.


ITEM 8.   FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

                          Index to Financial Statements
                                                                          Page

Balance Sheets - for the Years ended February 28, 1992 and 1991..........  6
Statement of Operations and Accumulated Deficit..........................  7
Statement of Cash Flows..................................................  8
Notes to Financial Statements............................................  9-10

     All other  schedules are not submitted  because they are not  applicable or
not required or because the information is included in the financial  statements
or notes thereto.

ITEM 9.   CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON
          ACCOUNTING AND FINANCIAL DISCLOSURE.

     None.


                                     Page 5

<PAGE>

                                MEDICAL MONITORS
                                 BALANCE SHEETS
                           FEBRUARY 28, 1992 AND 1991

<TABLE>
<CAPTION>
 
                                     ASSETS

                                                1992                1991
                                             (Unaudited)         (Unaudited)
                                             -----------         ------------
<S>                                          <C>                 <C>
CURRENT ASSETS                               
  Cash                                       $                   $          
  Accounts Receivable                                                       
  Inventory                                                                 
                                             -----------         ------------
  TOTAL CURRENT ASSETS                               -                    -
                                             -----------         ------------

PROPERTY AND EQUIPMENT - NET                                              -
                                             -----------         ------------
OTHER ASSETS                                         -                    -

TOTAL OTHER ASSETS                                   -                    -
                                             -----------         -------------
                                             $       -            $        -
                                             ===========         =============

                      LIABILITIES AND STOCKHOLDERS' EQUITY

CURRENT LIABILITIES

  Notes payable (Note 3)                     $   485,448          $   485,448
  Accrued officer's salaries (Note 4)            283,464              283,464
                                             -----------         ------------
  TOTAL CURRENT LIABILITIES                      768,912              768,912
                                             -----------         ------------

SHAREHOLDERS' DEFICIENCY 
  Common stock-authorized 50,000,000 shares,
     $.001 par value; issued & outstanding -
     50,000,000 shares in 1992 and 1991           50,000               50,000
  Additional paid-in capital                   1,141,299            1,141,299
  Accumulated deficit                        ( 1,960,211)         ( 1,960,211)
                                             -----------         ------------

TOTAL SHAREHOLDERS' DEFICIENCY               (   768,912)         (   768,912)
                                             -----------         ------------

                                             $        -          $        -
                                             ============        ============
</TABLE>

                 See accompanying Notes to Financial Statements.

                                     Page 6

<PAGE>      
                                MEDICAL MONITORS
                STATEMENTS OF OPERATIONS AND ACCUMULATED DEFICIT
                 FOR THE YEARS ENDED FEBRUARY 28, 1992 AND 1991
<TABLE>
<CAPTION>
 
                                                1992                1991
                                             (Unaudited)         (Unaudited)
                                             -----------         ------------
<S>                                          <C>                 <C>
Revenues                                     $                   $     

Cost and expenses
                                             -----------         ------------

Net income (loss)                                   
                                             -----------         ------------

Accumulated deficit, beginning of year       (1,960,211)           (1,960,211)
                                             -----------         ------------

Accumulated deficit, end of year             (1,960,211)         $ (1,960,211)
                                             ===========         ============

Net income (loss) per share                  $        -          $         -
                                             ===========         ============

Weighted average number of common 
shares outstanding                            50,000,000           50,000,000
                                             ===========         ============

</TABLE>

                 See accompanying Notes to Financial Statements.

                                     Page 7
<PAGE>


                                MEDICAL MONITORS
                            STATEMENTS OF CASH FLOWS
                 FOR THE YEARS ENDED FEBRUARY 28, 1992 AND 1991
<TABLE>
<CAPTION>
 
                                                1992                1991
                                             (Unaudited)         (Unaudited)
                                             -----------         ------------
<S>                                          <C>                 <C>
CASH FLOWS FROM OPERATING ACTIVITIES         $                   $
     
CASH USED IN OPERATING ACTIVITIES              
                                             
CASH USED IN INVESTING ACTIVITIES                                
                                                                                          
CASH FLOWS FROM FINANCING ACTIVITIES
                                             
NET INCREASE (DECREASE) IN CASH                

CASH, BEGINNING OF YEAR                              
                                             -------------       ------------
CASH, END OF YEAR                            $         -         $        -   
                                             =============       ============

</TABLE>

                 See accompanying Notes to Financial Statements.

                                     Page 8

<PAGE>

                                MEDICAL MONITORS
                          NOTES TO FINANCIAL STATEMENTS
                           FEBRUARY 28, 1992 AND 1991
                                   (UNAUDITED)

1.   SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES.

     Description  of  Business - Medical  Monitors,  Inc.  (the  "Company")  was
     incorporated  in Delaware in February 1975.  Initially,  its purpose was to
     develop and market blood  pressure  measuring  devices.  In April 1980, the
     Company  raised  $884,000  from the initial  public  offering of its common
     stock.  Because  the  Company  was unable to raised  additional  capital to
     continue  developing  and  marketing  its product,  in the Fall of 1981, it
     ceased its  operations.  In 1986,  the Company  ceased  making the required
     public  filings under the  Securities and exchange Act of 1934, as amended.
     The Board of  Directors  of the  Company  is  currently  investigating  the
     possibility   of  a  new  business   direction  and  searching  for  viable
     acquisition or merger candidates which would enable the Company to maximize
     value to its shareholders.

     Use of Estimates - The  preparation  of financial  statements in conformity
     with generally accepted  accounting  principles requires management to make
     estimates and assumptions that affect the amounts reported in the financial
     statements and accompanying  notes.  Actual results could differ from those
     estimates.

     Income  Taxes - Income  taxes  are  provided  using the  liability  method.
     Deferred  tax  assets and  liabilities  are  recognized  for the future tax
     consequences  attributable to differences  between the financial  statement
     carrying  amounts of existing assets and  liabilities and their  respective
     tax basis (i.e., temporary differences).

     Net Income  (Loss) Per Share - Net  Income  (loss) per share is  calculated
     using the weighted  average  number of common  shares  outstanding.  Common
     share equivalents are included to the extent they are dilutive.

2.   GOING CONCERN.

     The  Company  ceased  its  operations  in the Fall of 1981.  The  Company's
     ability to continue as a going concern will be dependent  upon  obtaining a
     viable business  through merger or  acquisition.  There can be no assurance
     that the Company will be able to find a business to acquire or merge with.

3.   NOTES PAYABLE.

     Notes payable consisted of the following at February 28, 1992 and 1991:

                                                     1992               1991
                                                  -----------        ----------
     Non-interest bearing advances payable
     To H. Shuster                                $  84,865          $  84,865

     Non-interest bearing notes payable
     to Loma Vista, Ltd.                            379,833            379,833


                                     Page 9
<PAGE>      

     Non-interest bearing note payable
     to European Diamond trading Corporation         20,750             20,750
                                                  -----------         ---------
                                                  $  485,448          $485,448
                                                  ===========         =========

     A  portion  of the notes  payable  to Loma  Vista,  Ltd.  In the  amount of
     $304,000  is secured  by all  assets of the  Company.  Harry  Shuster,  the
     President of the Company, is the sole general partner of Loma Vista, Ltd.

     Harry Shuster is an officer and majority  shareholder  of European  Diamond
     Trading Corporation.

     All of the above notes are in default.

     
4.   ACCRUED OFFICER'S SALARIES.

     Accrued officer's salaries consisted of amounts due Harry Shuster under his
     employment agreement which expired in December 1981.


                                    Page 10

<PAGE>

                                    PART III

Item 10.  Directors and Executive officers of the Registrant.

     The following table sets forth certain information concerning the Directors
and executive officers of the Company.

                                                                         A
                   Age   Principal Occupation and all                Director
Name                     Positions With the Company                    Since
-------------------------------------------------------------------------------
Harry Shuster            Director and  Chief Executive Officer          1975
                         President, Secretary and Chief
                         Financial Officer                              1986

     Harry  Shuster is a founder of the Company and has been its Chairman of the
Bard,  President  and a Director  since its  inception  in February,  1975.  Mr.
Shuster was also  Treasurer of the Company  until  August,  1981.  In 1967,  Mr.
Shuster founded Lion Country  Safari,  Inc. a  publicly-held  corporation  whose
Common Stock is registered under Section 12(g) of the Securities Exchange Act of
1934,  which operates an African  wildlife  preserve and theme amusement park in
Irvine,  California. Mr. Shuster has served as Lion Country Safari, Inc.'s chief
executive  officer and a director  since 1967, in which capacity he has directed
the  marketing  and  promotional  efforts  relating to the Lion  Country  Safari
operations.  Since  March,  1976,  Mr.  Shuster  has served  under a  consulting
agreement  which does not require his full-time  services in such capacities for
Lion  Country  Safari,  Inc.  It is  estimated  that  approximately  20%  of Mr.
Shuster's business working hours were devoted to his position as Chief Executive
Officer of the Company during the fiscal year ended February 28, 1985. Since the
Company moved into an inactive  status in late 1981,  Mr. Shuster has only spent
so much of his time on the  business and affairs of the Company as his duties as
Chief Executive Officer have required.  Accordingly,  Mr.. Shuster's services to
Lion Country  Safari Inc.  have  occupied more and more of his working time and,
from  time-to-time will likely continue to restrict the amount of time which Mr.
Shuster  can  make  available  to  the  Company's   business.   See  "Management
Compensations" and "Certain  Relationships and Related Transactions" in items 11
and 13,  respectively,  of this Annual  Report on Form 10-K.  Mr.  Shuster is an
attorney admitted to the Supreme Court of South Africa.

     The  present  term of each  Director  will  expire  at the time of the next
Annual Meeting of  Stockholders of the Company.  Executive  officers are elected
each year at the  Annual  Meeting  of the Board of  Directors  held  immediately
following  the Annual  Meeting of  Stockholders  and hold office  until the next
Annual  Meeting of the Board of  Directors  or until their  successors  are duly
elected and qualified.  The Company has held no Annual  Meeting of  Shareholders
since August 26, 1980.

     There are no  arrangements or  understandings  known to the Company between
any of the  Directors or executive  officers of the Company and any other person
pursuant to which any of such  persons was or is to be selected as a Director or
an executive officer.  There are no family relationships between any Director or
executive officer and any other Director or executive officer of the Company.

     The Board of Directors has held no formal  meetings since 1983. The Company
has no standing  audit,  nominating or  compensation  committees of the Board of
Directors.

                                    Page 11

<PAGE>

Item 11.  Management Compensation

Management Compensation

     No officer or Director of the Company either received or had accrued on the
books of the  Company  any  remuneration  with  respect to the fisca1 year ended
February 28, 1992.

     There was no health or life insurance  provided to officers or Directors by
the Company which  discriminates  in favor of officers or Directors and which is
not available  generally to all salaried  employees of the Company.  The Company
has no  employee  incentive,  bonus or  benefit  plans,  profit  sharing  plans,
retirement plans, deferred  compensation plans or similar arrangements.  No fees
are paid  Directors  for  attendance  at  meetings  of the  Board of  Directors,
although out-of-pocket expenses incurred in connection therewith are reimbursed.

Item 12.  Security Ownership of Certain Beneficial Owners and Management

     The  following  table sets forth  certain  information  with respect to all
persons,  or groups of persons,  known by the Company to own  beneficially  more
than five percent of the Common Stock, $.01 par value, of the Company,  its only
outstanding  class of  voting  securities,  and as to the  beneficial  ownership
thereof of the  Directors of the Company,  individually,  and all  Directors and
officers as a group, all as at February 28, 1992.

Name and Address of                Amount and Nature or
Beneficial Owner (a)               Beneficial Ownership          Percentages(b)
--------------------               --------------------          --------------
Harry Shuster
1900 Westwood Blvd.
Los Angeles, California 90025          16,082,088                    32.16%

Loma Vista, Ltd.
c/o Harry Shuster
1900 Westwood Blvd.
Los Angeles, California 90025           3,318,985 (c)                 6.64%(c)

Richard Weisman
16200 Ventura Blvd.
Suite 201
Encino, California 91436                2,631,745 (d)                 5.26%(d)

All officers and Directors as
A Group (One person)                    19,401,073 (e)               38.80%(e)

---------------- 
     (a)  Addresses  are  shown  only  for the  beneficial  owners  of at  least
five-percent of the Common Stock of the Company.

     (b)  Percentages  are  determined  on the  basis of  50,000,000  shares  of
outstanding Common Stock.

     (c) Loma  Vista  Ltd.  is a limited  partnership  of which  Harry  Shuster,
Chairman of the Board,  President and Chief Executive Officer of the Company, is
the general  partner and through which Mr.  Shuster has an interest in shares of
the Company's  Common Stock. A portion of the shares  originally  issued to Loma
Vista,  Ltd. were  subsequently  distributed to several of its limited partners.
All of the shares now owned by Loma Vista,  Ltd. are allocated to Mr.  Shuster's
general  partner's  interest in such limited  partnership.  

       

                             Page 12
<PAGE>
     (d) Mr. Weisman,  a former Director of the Company,  holds 545,106 of these
shares  directly,  86,000 as executor  of his  father's  estate,  and a total of
800,151  shares as trustee for his adult sons.  As to all of these  shares,  Mr.
Weisman can be said to have sole  investment  and voting  power.  The  remaining
shares are owned by Mr.  Weisman's  wife,  sister  and  mother  and Mr.  Weisman
disclaims any beneficial ownership thereof.

     (e) Includes shares owned by Loma Vista, Ltd.


                                    PART IV.

Item 13.  Certain Relationship and Related Transactions.

     The  following  table  outlines   certain   information   with  respect  to
obligations  of the  Company to its  present  principal  stockholders  and their
affiliates as of February 28, 1992.

                                                  Accrued
                    Purchase         Loans         for           Total Due
                     AES            to the        Services       At End of
Obligee             Rights          Company       Rendered        year
------------------------------------------------------------------------------
Loma Vista, Ltd.    $ 75,833(1)    $304,000 (1)   $   -          $379,833
European
Diamond Trading
Corporation (2)                      20,750                        20,750
Harry Shuster                        84,865           -            84,865
------------------------------------------------------------------------------
                    $ 75,833       $409,615       $283,464     $  768,912
                    ========       ========       ========     ==========

     (1) This note is secured by a pledge of all  assets of the  Company.  These
notes are  presently in default,  but payment  "thereof has not been demanded by
Loma Vista, Ltd. See Note 3 of "Notes to Financial Statements".

     (2) These demand notes are payable to European Diamond Trading Corporation,
a corporation controlled by Harry Shuster,  Chairman of the Board, President and
Chief Executive Officer of the Company.

     All of the above notes are in default.

                                    Page 13

<PAGE>

                                     PART IV

Item 14.  EXHIBITS, FINANCIAL STATEMENT SCHEDULES AND
          REPORTS ON FORM 8-K

     (a) Documents filed as a part of this report:

     (1)  Financial  Statements  of the  Registrant.  set forth under Item 8 are
     filed as part of this report.

     (2) The Financial  Statement  Schedules  other than those listed above have
     been omitted because they are either not required,  not applicable,  or the
     information is otherwise included.

     (b) Information filed as part of this report from Form 8-K:

     (1) No reports on Form 8-K were filed during the last quarter of the period
     covered by this report.


                                    Page 14

<PAGE>


                                   SIGNATURES

         Pursuant to the  requirements  of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.

                                                  MEDICAL MONITORS, INC.
                                                    (Registrant)


 Date: March 12, 1998                              /S/ Harry Shuster
                                                  ------------------------------
                                                  By: Harry Shuster
                                                  Its: President, Secretary and
                                                       Chief Financial Officer

                                    Page 15